Researchers from Mount Sinai published findings on October 1, 2026, in the American Journal of Psychiatry, identifying three specific brain pathways linked to lasting improvements in deep brain stimulation (DBS) therapy for severe, treatment-resistant depression. This discovery suggests that minute differences in electrode placement, down to the millimeter, can significantly influence treatment outcomes for patients.

This research offers a more precise understanding of how deep brain stimulation works, potentially leading to more effective and consistent outcomes for individuals with treatment-resistant depression who have exhausted other options.

What the records show

The study identified the cingulum bundle, the forceps minor, and the medial uncinate fasciculus/ventral amygdalofugal pathways as key to sustained clinical improvement in patients receiving DBS. The research found that lasting improvements were consistently associated with electrical stimulation reaching these three specific white matter pathways. Conversely, patients who showed no improvement after two years of stimulation exhibited insufficient engagement of a vital brain connection. The findings indicate that effective stimulation needs to engage specific connections within a brain area, not just stimulate the area generally. The study examined the largest multi-cohort group to date of patients who received subcallosal cingulate deep brain stimulation (SCC DBS) for treatment-resistant depression.

The timeline

On October 1, 2026, the findings were published in the American Journal of Psychiatry.

What changed and for whom

This research shifts the understanding of effective deep brain stimulation from merely where an electrode is positioned to which specific brain connections its electrical field activates. The discovery could help refine how this investigational treatment is targeted, making it more precise and potentially more effective for patients with severe depression that has not responded to conventional treatments. The focus now turns to utilizing detailed maps of the brain's connections to guide electrode placement, rather than relying solely on anatomical landmarks.

What the Mount Sinai researchers reported

Scientists at Mount Sinai identified these important brain connections, noting that the discovery could help make this experimental therapy more precise and effective. Mount Sinai researchers reported that sustained improvement in people receiving DBS was tracked consistently with stimulation reaching the three specific pathways. They linked the sustained improvement to stimulation reaching several white matter pathways, stating that the result shifts the targeting question from an electrode's location to the network effects its electrical field engages.

What we could not confirm

We could not confirm specific individual researchers involved or quotes from them beyond what is stated in the published findings and news summaries.